Idorsia Company

Idorsia is a biopharmaceutical company based in Switzerland that aims to discover, develop and commercialize innovative medicines to help more patients. They have a strong scientific core and specialize in the discovery, development and commercialization of innovative small molecules to transform the horizon of therapeutic options. Their goal is to become a leading biopharmaceutical company.

Estimated Revenue: CHF 1,188 million
Funding Status: IPO
Employee Number: 1001-5000
Industry: BioTech
Headquarters: Allschwil
Founded Date: 2017
Total Funding: $1.4B
Technology: Small Molecules